TUDOR INVESTMENT CORP ET AL - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$132
-78.4%
49,297
-56.3%
0.00%
-83.3%
Q4 2022$612
-99.9%
112,746
+34.0%
0.01%
-47.8%
Q3 2022$1,051,000
+373.4%
84,119
+87.1%
0.02%
+283.3%
Q2 2022$222,000
-62.2%
44,964
+37.9%
0.01%
-64.7%
Q4 2020$587,000
+90.0%
32,607
+22.0%
0.02%
+30.8%
Q3 2020$309,000
+13.2%
26,732
+411.4%
0.01%
+85.7%
Q3 2018$273,0005,2270.01%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders